Skip to main content
Home
Center for Technology Transfer & Commercialization
  • Home
  • About
  • Inventors
  • Industry
  • Startup Support
  • News & Events
  • Contact Us
  • Quick Links

Search form

Stephen Fesik
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • YouTube icon

Displaying 1 - 3 of 3


Vanderbilt-discovered cancer killing compound is now available through Boehringer Ingelheim open science portal opnMe

Researchers in the lab of Stephen Fesik, Orrin H.


  • Read more about Vanderbilt-discovered cancer killing compound is now available through Boehringer Ingelheim open science portal opnMe
Related Categories: 
Alex Waterson Biochemistry Boehringer Ingelheim cancer Department of Energy KRAS Lustgarten Foundation National Institutes of Health opnMe School of Medicine Basic Sciences Stephen Fesik Vanderbilt Institute for Chemical Biology

Cancer’s SOS

Cancer’s SOS - New Research From Stephen Fesik and Colleagues


  • Read more about Cancer’s SOS
Related Categories: 
Research ACS Chemical Biology Basic Sciences Drug Discovery department of biochemistry Department of Chemistry Department of Pharmacology g protein Lustgarten Foundation Stephen Fesik

Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer

Boehringer Ingelheim & Vanderbilt University expand partnership to develop novel treatment approaches for cancer


  • Read more about Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer
Related Categories: 
Stephen Fesik Boehringer Ingelheim cancer MCL1
Center for Technology Transfer & Commercialization
2100 West End Ave, Suite 750
Nashville, TN 37203
Tel: 615.343.2430
 
© 2014 -2025 Vanderbilt University
Send message